Induction of interleukin 2 expression in the liver for the treatment of H22 hepatoma in mice
Autor: | Wei Cheng, Yan-ru Li, Hai-Ying Zhang, Ou Yang, Lin Wang, Lanfang Miao, He Ge |
---|---|
Rok vydání: | 2013 |
Předmět: |
Interleukin 2
Transgene Spleen Biology Transfection Polymerase Chain Reaction Flow cytometry Mice Hormone Antagonists Liver Neoplasms Experimental Plasmid Cell Line Tumor medicine Animals RNA Messenger Cell Proliferation DNA Primers Mice Inbred BALB C Messenger RNA Hepatology medicine.diagnostic_test Gastroenterology Flow Cytometry Molecular biology Mifepristone Treatment Outcome medicine.anatomical_structure Gene Expression Regulation Cell culture Interleukin-2 Drug Therapy Combination Female hormones hormone substitutes and hormone antagonists Plasmids medicine.drug |
Zdroj: | Digestive and Liver Disease. 45:50-57 |
ISSN: | 1590-8658 |
DOI: | 10.1016/j.dld.2012.08.014 |
Popis: | Background and aims We designed this study to evaluate the ability of a plasmid carrying an RU486 regulatory system to induce expression of interleukin-2 (IL-2) gene and to examine the antitumour efficacy of the induced IL-2 gene. Methods The plasmid pRS-mIL-2,which contains an RU486 inducible system and IL-2 gene was injected into mice. Sera and tissues from liver, spleen, lungs and kidneys were taken to test the properties of the plasmid. To examine the antitumour efficacy of pRS-mIL-2, tumours were established in the liver by direct inoculation of H22 hepatoma cells. Results The IL-2 levels in serum correlated with the dose of plasmid and RU486. High and sustained IL-2 levels could be achieved by administration of RU486 every day. The mRNA of transgene IL-2 was found only in the liver. Treatment of mice with pRS-mIL-2 plus RU486 resulted in the significant reduction in tumour volume compared with control groups. Conclusions Tight temporal and spatial control of transgene IL-2 expression can be achieved by a plasmid containing an RU486 inducible system driven by liver specific promoter. pRS-mIL-2 exhibited strong antitumour efficacy following consecutive induction with RU486. |
Databáze: | OpenAIRE |
Externí odkaz: |